COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025 -
-
-
COMMUNIQUÉ DE PRESSE
Amin Wasserman Gurnani Welcomes Former Acting Director for FDA's Office of Dietary Supplement Programs as Co-Chair of the Firm's Regulatory Group
Robert Durkin appointed as co-lead of regulatory practice at Amin Wasserman Gurnani alongside Rend Al-Mondhiry in Washington, D.C., bringing extensive FDA experience and strategic insight -
COMMUNIQUÉ DE PRESSE
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2024
Dassault Systèmes declares number of outstanding shares and voting rights as of June 30, 2024, per regulations. Encourages shareholders to refer for threshold crossing declarations -
-
COMMUNIQUÉ DE PRESSE
Pathfinder Ventures Announces Non-Brokered Private Placement of up to $1 Million and Concurrent Share Consolidation
Pathfinder Ventures Inc. announces non-brokered private placement & consolidation plans for enhanced financing flexibility. Net proceeds to support RV Resort developments & acquisitions -
